Kiniksa price target raised to $42 from $30 at Wells Fargo

Wells Fargo raised the firm’s price target on Kiniksa (KNSA) to $42 from $30 and keeps an Overweight rating on the shares. The firm’s Q2 Arcalyst estimates of $146M are in line with the Street, and it forecasts continued growth through 2025. As KPL-387’s trial initiates in mid-25, all eyes are on Arcalyst this year and its market share in early lines, adds Wells.